Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 1
1950 6
1951 3
1952 1
1953 7
1954 1
1955 4
1956 2
1957 5
1958 3
1961 3
1962 1
1965 4
1966 1
1967 1
1972 1
1973 1
1976 3
1977 3
1978 6
1979 2
1980 2
1981 1
1982 4
1983 4
1984 1
1985 2
1986 3
1987 2
1988 5
1989 5
1990 2
1991 1
1992 7
1993 6
1994 9
1995 13
1996 9
1997 9
1998 9
1999 4
2000 4
2001 5
2002 3
2003 9
2004 7
2005 5
2006 10
2007 10
2008 4
2009 11
2010 10
2011 7
2012 12
2013 17
2014 14
2015 21
2016 23
2017 27
2018 13
2019 17
2020 21
Text availability
Article attribute
Article type
Publication date

Search Results

380 results
Results by year
Filters applied: . Clear all
Page 1
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Rivière F, Janicot H, Gervais R, Locher C, Milleron B, Tran Q, Lebitasy MP, Morin F, Creveuil C, Parienti JJ, Scherpereel A; French Cooperative Thoracic Intergroup (IFCT). Zalcman G, et al. Among authors: morin f. Lancet. 2016 Apr 2;387(10026):1405-1414. doi: 10.1016/S0140-6736(15)01238-6. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719230 Clinical Trial.
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Pujol JL, Sabourin JC, Penault-Llorca F, Denis MG, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria JC, Zalcman G; Biomarkers France contributors. Barlesi F, et al. Among authors: morin f. Lancet. 2016 Apr 2;387(10026):1415-1426. doi: 10.1016/S0140-6736(16)00004-0. Epub 2016 Jan 15. Lancet. 2016. PMID: 26777916 Free article.
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Scherpereel A, Mazieres J, Greillier L, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, Audigier-Valette C, Locatelli-Sanchez M, Molinier O, Guisier F, Urban T, Ligeza-Poisson C, Planchard D, Amour E, Morin F, Moro-Sibilot D, Zalcman G; French Cooperative Thoracic Intergroup. Scherpereel A, et al. Among authors: morin f. Lancet Oncol. 2019 Feb;20(2):239-253. doi: 10.1016/S1470-2045(18)30765-4. Epub 2019 Jan 16. Lancet Oncol. 2019. PMID: 30660609 Clinical Trial.
Outpatient management of pediatric acute mastoiditis.
Alkhateeb A, Morin F, Aziz H, Manogaran M, Guertin W, Duval M. Alkhateeb A, et al. Among authors: morin f. Int J Pediatr Otorhinolaryngol. 2017 Nov;102:98-102. doi: 10.1016/j.ijporl.2017.09.008. Epub 2017 Sep 11. Int J Pediatr Otorhinolaryngol. 2017. PMID: 29106885
Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.
Joncas FH, Lucien F, Rouleau M, Morin F, Leong HS, Pouliot F, Fradet Y, Gilbert C, Toren P. Joncas FH, et al. Among authors: morin f. Prostate. 2019 Nov;79(15):1767-1776. doi: 10.1002/pros.23901. Epub 2019 Sep 2. Prostate. 2019. PMID: 31475741
Lung cancer in never smokers--a review.
Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ. Couraud S, et al. Among authors: morin f. Eur J Cancer. 2012 Jun;48(9):1299-311. doi: 10.1016/j.ejca.2012.03.007. Epub 2012 Mar 28. Eur J Cancer. 2012. PMID: 22464348 Review.
Endozepines and their receptors: Structure, functions and pathophysiological significance.
Tonon MC, Vaudry H, Chuquet J, Guillebaud F, Fan J, Masmoudi-Kouki O, Vaudry D, Lanfray D, Morin F, Prevot V, Papadopoulos V, Troadec JD, Leprince J. Tonon MC, et al. Among authors: morin f. Pharmacol Ther. 2020 Apr;208:107386. doi: 10.1016/j.pharmthera.2019.06.008. Epub 2019 Jul 5. Pharmacol Ther. 2020. PMID: 31283949 Review.
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial.
Pujol JL, Greillier L, Audigier-Valette C, Moro-Sibilot D, Uwer L, Hureaux J, Guisier F, Carmier D, Madelaine J, Otto J, Gounant V, Merle P, Mourlanette P, Molinier O, Renault A, Rabeau A, Antoine M, Denis MG, Bommart S, Langlais A, Morin F, Souquet PJ. Pujol JL, et al. Among authors: morin f. J Thorac Oncol. 2019 May;14(5):903-913. doi: 10.1016/j.jtho.2019.01.008. Epub 2019 Jan 18. J Thorac Oncol. 2019. PMID: 30664989 Clinical Trial.
Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.
Boulanger Piette A, Hamoudi D, Marcadet L, Morin F, Argaw A, Ward L, Frenette J. Boulanger Piette A, et al. Among authors: morin f. Curr Osteoporos Rep. 2018 Oct;16(5):541-553. doi: 10.1007/s11914-018-0468-2. Curr Osteoporos Rep. 2018. PMID: 30225627 Review.
Safety and efficacy of Tamsulosin as medical expulsive therapy in pregnancy.
Theriault B, Morin F, Cloutier J. Theriault B, et al. Among authors: morin f. World J Urol. 2020 Sep;38(9):2301-2306. doi: 10.1007/s00345-019-03022-z. Epub 2019 Nov 25. World J Urol. 2020. PMID: 31768615
380 results
Jump to page
Feedback